• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIAC ASSIST INC. PROTEKDUO VENO-VENOUS CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIAC ASSIST INC. PROTEKDUO VENO-VENOUS CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 5140-5131
Device Problem Insufficient Information (3190)
Patient Problem Pulmonary Valve Insufficiency/ Regurgitation (4452)
Event Type  Injury  
Manufacturer Narrative
A1.-a6.No patient information was provided.D4.No serial number(s) has been provided, so udi and expiration date could not be determined.H4.As a serial number has not been provided, manufacture date is unknown.H10.Livanova manufactures the protekduo.The event occurred in (b)(6).Livanova has attempted to gather additional information about the event, including details of each event (e.G.Event date), the alleged relationship between the events and the livanova device, and other information about what has occurred.During a discussion with dr.Brewer, he indicated that specific details regarding this event (e.G.Event date, patient information, device information, etc.) were not recorded and could not be provided.During the follow-up communication, dr.Brewer indicated that severe tricuspid regurgitation was identified on a patient who suffered from rv disfunction prior to surgery, and the protekduo needed to be run at a higher rate in order to get septal balance.The customer did not know the valve condition prior to implantation and believes the device contributed to the regurgitation in some way.The patient was on support for 24-48 hours prior to the event and remained on the protekduo for 10-14 days following the event without any complications.At this time, there is no known malfunction of the protekduo that has been reported and it is unclear if any relationship exists between the reported adverse events and the livanova device.The customer believes the device contributed in some way, but no specific malfunction has been identified.As device information was not provided, a review of the dhr could not be performed.If any additional information pertinent to the reported event is received, it will be provided in a supplemental report.H3 other text : device(s) has not been made available.
 
Event Description
Livanova received a report from a physician who stated that they noticed a patient with severe pulmonic insufficiency after placing the protekduo 31fr cannula while on support for 24-28 hrs.The patient had the protekduo remain in place without any complications but had to run at a higher speed for 10-14 days.The patient was reportedly still in icu at the time the event was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEKDUO VENO-VENOUS CANNULA
Type of Device
CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
CARDIAC ASSIST INC.
620 alpha drive
pittsburgh PA 15238
Manufacturer (Section G)
CARDIAC ASSIST INC.
620 alpha drive
pittsburgh PA 15238
Manufacturer Contact
ryan coyle
620 alpha drive
pittsburgh, PA 15238
MDR Report Key18114854
MDR Text Key327883656
Report Number2531527-2023-00036
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K160257
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number5140-5131
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/13/2023
Initial Date FDA Received11/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-